Noticeably, Flanagan et al. (2017) reported that teratoma was diagnosed in 71% of patients with the coexistence of NMDA-R–IgG and AQP4-IgG and 53% of patients with the coexistence of NMDA-R–IgG alone. This evidence concerns the gene AQP4 and teratoma.